CDT Equity (FRA:ZK70) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZK70 CDT Equity Inc FRA:ZK70
11 GF Score
Price €92,610.00
! 5 Warning Signs
View Full Analysis

What is CDT Equity FFO?

FFO (Funds from operations) only applies to REITs.

FRA:ZK70
11GF Score
CDT Equity Inc FRA:ZK70
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CDT Equity Business Description

Other Exchanges CDT:USA
Address 4581 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
11GF Score

Get the complete analysis for FRA:ZK70

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€92,610.00
Price